1189 ONCE-DAILY NS5A INHIBITOR (BMS-790052) PLUS PEGINTERFERON-ALPHA-2A AND RIBAVIRIN PRODUCES HIGH RATES OF EXTENDED RAPID VIROLOGIC RESPONSE IN TREATMENT-NAIVE HCV-GENOTYPE 1 SUBJECTS: PHASE 2A TRIAL

Authors :: Christophe Hézode
Joseph K. Lim
H.A. Tatum
Reem Ghalib
U. Diva
R. Hindes
Philip D. Yin
G.T. Everson
Claudia Martorell
Vinod K. Rustgi
Stanislas Pol
Source :: Journal of Hepatology. 52:S462
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: High rate
Hepatology
business.industry
Ribavirin
Peginterferon alpha-2a
Virology
Therapy naive
chemistry.chemical_compound
Hcv genotype 1
chemistry
Medicine
Once daily
business
Rapid Virologic Response
NS5A

Tools